Risk of recurrence lower with rivaroxaban than aspirin

被引：0
|
作者：
Karina Huynh
机构：
来源：
Nature Reviews Cardiology | 2017年 / 14卷
关键词：
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：254 / 255
页数：1
相关论文
共 50 条
  • [31] Rivaroxaban or Aspirin for Extended Treatment of Venous Thromboembolism
    Weitz, J. I.
    Lensing, A. W. A.
    Prins, M. H.
    Bauersachs, R.
    Beyer-Westendorf, J.
    Bounameaux, H.
    Brighton, T. A.
    Cohen, A. T.
    Davidson, B. L.
    Decousus, H.
    Freitas, M. C. S.
    Holberg, G.
    Kakkar, A. K.
    Haskell, L.
    van Bellen, B.
    Pap, A. F.
    Berkowitz, S. D.
    Verhamme, P.
    Wells, P. S.
    Prandoni, P.
    NEW ENGLAND JOURNAL OF MEDICINE, 2017, 376 (13): : 1211 - 1222
  • [32] Adding rivaroxaban to aspirin after CABG surgery
    Lim G.B.
    Nature Reviews Cardiology, 2019, 16 (3) : 133 - 133
  • [33] Rivaroxaban with or without Aspirin in Stable Cardiovascular Disease
    Eikelboom, J. W.
    Connolly, S. J.
    Bosch, J.
    Dagenais, G. R.
    Hart, R. G.
    Shestakovska, O.
    Diaz, R.
    Alings, M.
    Lonn, E. M.
    Anand, S. S.
    Widimsky, P.
    Hori, M.
    Avezum, A.
    Piegas, L. S.
    Branch, K. R. H.
    Probstfield, J.
    Bhatt, D. L.
    Zhu, J.
    Liang, Y.
    Maggioni, A. P.
    Lopez-Jaramillo, P.
    O'Donnell, M.
    Kakkar, A. K.
    Fox, K. A. A.
    Parkhomenko, A. N.
    Ertl, G.
    Stoerk, S.
    Keltai, M.
    Ryden, L.
    Pogosova, N.
    Dans, A. L.
    Lanas, F.
    Commerford, P. J.
    Torp-Pedersen, C.
    Guzik, T. J.
    Verhamme, P. B.
    Vinereanu, D.
    Kim, J. -H.
    Tonkin, A. M.
    Lewis, B. S.
    Felix, C.
    Yusoff, K.
    Steg, P. G.
    Metsarinne, K. P.
    Bruns, N. Cook
    Misselwitz, F.
    Chen, E.
    Leong, D.
    Yusuf, S.
    Aboyans, V.
    NEW ENGLAND JOURNAL OF MEDICINE, 2017, 377 (14): : 1319 - 1330
  • [34] Effect of combining aspirin and rivaroxaban on atherosclerosis in mice
    Grover, Steven P.
    Coughlin, Taylor
    Fleifil, Salma M.
    Posma, Jens J. N.
    Spronk, Henri H. M.
    Heitmeier, Stefan
    Owens, A. Phillip
    Mackman, Nigel
    ATHEROSCLEROSIS, 2022, 345 : 7 - 14
  • [35] Rivaroxaban with or without aspirin for prevention of cardiovascular disease
    Kruger, Paul C.
    Eikelboom, John W.
    Yusuf, Salim
    CORONARY ARTERY DISEASE, 2018, 29 (05) : 361 - 365
  • [36] A retrospective analysis of bleeding risk with rivaroxaban, enoxaparin, and aspirin following total joint arthroplasty or revision
    Watts, Paula J.
    Kopstein, Michael
    Harkness, Weston
    Cornett, Brendon
    Dziadkowiec, Oliwier
    Hicks, M. Elizabeth
    Hassan, Shakib
    Scherbak, Dmitriy
    PHARMACOTHERAPY, 2021, 41 (07): : 608 - 615
  • [37] Rivaroxaban and Aspirin in Patients With Symptomatic Lower Extremity Peripheral Artery Disease A Subanalysis of the COMPASS Randomized Clinical Trial
    Kaplovitch, Eric
    Eikelboom, John W.
    Dyal, Leanne
    Aboyans, Victor
    Abola, Maria Teresa
    Verhamme, Peter
    Avezum, Alvaro
    Fox, Keith A. A.
    Berkowitz, Scott D.
    Bangdiwala, Shrikant I.
    Yusuf, Salim
    Anand, Sonia S.
    JAMA CARDIOLOGY, 2021, 6 (01) : 21 - 29
  • [38] Concurrent Lower Gastrointestinal Bleeding Risk and Myocardial Ischemic Risk: Resume Aspirin or Not?
    Bhatt, Deepak L.
    Hunt, Richard H.
    GASTROENTEROLOGY, 2016, 151 (02) : 222 - 225
  • [39] Higher dose aspirin shown to reduced risk of recurrence of cardiovascular events
    Idris, Iskandar
    DIABETES OBESITY & METABOLISM, 2011, 13 (09): : 868 - 868
  • [40] Do aspirin and other NSAIDs lower risk of breast cancer?
    Bardia, A.
    Ebbert, J. O.
    Vierkant, R. A.
    Wang, A. H.
    Olson, J. E.
    Limburg, P.
    Anderson, K.
    Cerhan, J. R.
    CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION, 2008, 17 (02) : 461 - 461
12345